The A4 study is a clinical trial for older individuals who may be at risk for Alzheimer's disease (AD). The study aims to prevent the memory loss associated with Alzheimer’s disease (AD).
About the A4 Study
Are you eligible?
The A4 study has specific eligibility requirements for potential participants. Review the requirements to learn if you can join the A4 study. If you have any questions regarding eligibility, contact the A4 study today.
The A4 study is a landmark public-private partnership, funded by the National Institute on Aging/NIH, Eli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the University of Southern California’s Alzheimer’s Therapeutic Research Institute, with study sites in multiple locations.